A randomized controlled trial published in JAMA Network Open reveals that the probiotic Bifidobacterium animalis subsp. lactis had no significant impact on bowel health among participants with constipation, diminishing claims about its efficacy in improving digestion.
Despite numerous marketing campaigns promoting probiotics as beneficial for gut health, including products like Dannon's Activia yogurt, scientific evidence supporting these claims remains weak and inconclusive, highlighting a need for scrutinizing their effectiveness.
The study involved 228 participants suffering from functional constipation, allowing for an objective assessment of the probiotic's health claims. Results indicated no improvement in bowel movements or overall gut health in those consuming the probiotic versus placebo.
This trial underscores the significance of relying on robust clinical evidence rather than advertising, prompting consumers to evaluate the legitimacy of health benefits promoted by probiotic companies, which may sometimes be misleading.
Collection
[
|
...
]